HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel use of a double lumen balloon catheter for venous sinus thrombolysis and venoplasty.

Abstract
We describe the novel use of a double lumen balloon catheter for venous sinus thrombolysis and venoplasty. Cerebral venous sinus thrombosis is a rare disease that is usually treated with medical anticoagulation. In certain refractory cases, surgical or endovascular thrombolysis and thrombectomy may be required. A 48 year-old man on anticoagulation for cerebral venous sinus thrombosis presented with nausea, vomiting and worsening hemiparesis. The patient underwent endovascular venous sinus thrombolysis and venoplasty with continuous in situ tissue plasminogen activator (tPA) infusion over 48 hours. This novel approach to the endovascular treatment of venous sinus thrombosis, including the use of a double lumen balloon was advantageous, as it allowed direct infusion of tPA through the balloon catheter without having to exchange the balloon for a microcatheter.
AuthorsNajib E El Tecle, Biraj M Patel, Tarek Y El Ahmadieh, Marc R Daou, Youssef J Hamade, Samer G Zammar, Ali Shaibani, Bernard R Bendok
JournalJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (J Clin Neurosci) Vol. 22 Issue 6 Pg. 1018-20 (Jun 2015) ISSN: 1532-2653 [Electronic] Scotland
PMID25863997 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2015. Published by Elsevier Ltd.
Chemical References
  • Fibrinolytic Agents
  • Tissue Plasminogen Activator
Topics
  • Catheters
  • Endovascular Procedures (instrumentation, methods)
  • Fibrinolytic Agents (administration & dosage)
  • Humans
  • Male
  • Middle Aged
  • Sinus Thrombosis, Intracranial (drug therapy)
  • Thrombolytic Therapy (instrumentation)
  • Tissue Plasminogen Activator (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: